Cargando…
Current status of surgical treatment of colorectal liver metastases
Liver metastasis (LM) is one of the major causes of death in patients with colorectal cancer (CRC). Approximately 60% of CRC patients develop LM during the course of their illness. About 85% of these patients have unresectable disease at the time of presentation. Surgical resection is currently the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264988/ https://www.ncbi.nlm.nih.gov/pubmed/30510936 http://dx.doi.org/10.12998/wjcc.v6.i14.716 |
_version_ | 1783375591321370624 |
---|---|
author | Xu, Feng Tang, Bin Jin, Tian-Qiang Dai, Chao-Liu |
author_facet | Xu, Feng Tang, Bin Jin, Tian-Qiang Dai, Chao-Liu |
author_sort | Xu, Feng |
collection | PubMed |
description | Liver metastasis (LM) is one of the major causes of death in patients with colorectal cancer (CRC). Approximately 60% of CRC patients develop LM during the course of their illness. About 85% of these patients have unresectable disease at the time of presentation. Surgical resection is currently the only curative treatment for patients with colorectal LM (CRLM). In recent years, with the help of modern multimodality therapy including systemic chemotherapy, radiation therapy, and surgery, the outcomes of CRLM treatment have significantly improved. This article summarizes the current status of surgical treatment of CRLM including evaluation of resectability, treatment for resectable LM, conversion therapy and liver transplantation for unresectable cases, liver resection for recurrent CRLM and elderly patients, and surgery for concomitant hepatic and extra-hepatic metastatic disease (EHMD). We believe that with the help of modern multimodality therapy, an aggressive oncosurgical approach should be implemented as it has the possibility of achieving a cure, even when EHMD is present in patients with CRLM. |
format | Online Article Text |
id | pubmed-6264988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-62649882018-12-03 Current status of surgical treatment of colorectal liver metastases Xu, Feng Tang, Bin Jin, Tian-Qiang Dai, Chao-Liu World J Clin Cases Review Liver metastasis (LM) is one of the major causes of death in patients with colorectal cancer (CRC). Approximately 60% of CRC patients develop LM during the course of their illness. About 85% of these patients have unresectable disease at the time of presentation. Surgical resection is currently the only curative treatment for patients with colorectal LM (CRLM). In recent years, with the help of modern multimodality therapy including systemic chemotherapy, radiation therapy, and surgery, the outcomes of CRLM treatment have significantly improved. This article summarizes the current status of surgical treatment of CRLM including evaluation of resectability, treatment for resectable LM, conversion therapy and liver transplantation for unresectable cases, liver resection for recurrent CRLM and elderly patients, and surgery for concomitant hepatic and extra-hepatic metastatic disease (EHMD). We believe that with the help of modern multimodality therapy, an aggressive oncosurgical approach should be implemented as it has the possibility of achieving a cure, even when EHMD is present in patients with CRLM. Baishideng Publishing Group Inc 2018-11-26 2018-11-26 /pmc/articles/PMC6264988/ /pubmed/30510936 http://dx.doi.org/10.12998/wjcc.v6.i14.716 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Review Xu, Feng Tang, Bin Jin, Tian-Qiang Dai, Chao-Liu Current status of surgical treatment of colorectal liver metastases |
title | Current status of surgical treatment of colorectal liver metastases |
title_full | Current status of surgical treatment of colorectal liver metastases |
title_fullStr | Current status of surgical treatment of colorectal liver metastases |
title_full_unstemmed | Current status of surgical treatment of colorectal liver metastases |
title_short | Current status of surgical treatment of colorectal liver metastases |
title_sort | current status of surgical treatment of colorectal liver metastases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264988/ https://www.ncbi.nlm.nih.gov/pubmed/30510936 http://dx.doi.org/10.12998/wjcc.v6.i14.716 |
work_keys_str_mv | AT xufeng currentstatusofsurgicaltreatmentofcolorectallivermetastases AT tangbin currentstatusofsurgicaltreatmentofcolorectallivermetastases AT jintianqiang currentstatusofsurgicaltreatmentofcolorectallivermetastases AT daichaoliu currentstatusofsurgicaltreatmentofcolorectallivermetastases |